文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

粪菌移植与氢化可的松改善盲肠结扎穿孔脓毒症大鼠的肠道屏障功能并提高生存率

Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis.
PubMed 文献 · Shock · 2021-01-01
一句话结论大鼠CLP脓毒症模型中,氢化可的松2.8 mg/kg单次腹腔注射或粪菌移植可降低50%死亡率并改善肠屏障指标。

研究在大鼠盲肠结扎穿孔(CLP)脓毒症模型中比较假手术组、CLP组、CLP+氢化可的松(2.8 mg/kg腹腔单次给药,6小时)组和CLP+粪菌移植(6小时)组。24小时取回肠组织行组织学和免疫组化分析,并检测循环内毒素、IL-6、IL-10;第二实验观察7天死亡率,存活大鼠每日给予氢化可的松或粪菌移植。结果显示两种干预均使脓毒症大鼠死亡率降低50%,逆转肠黏膜萎缩、减少隐窝凋亡小体、降低活化caspase-3表达、增加潘氏细胞计数、降低上皮内CD3+ T淋巴细胞和固有层炎症浸润,并提高紧密连接蛋白occludin和claudin-1表达,降低全身内毒素血症;粪菌移植还降低IL-6和IL-10水平。

要点

  • 大鼠CLP脓毒症模型中,氢化可的松(2.8 mg/kg腹腔单次给药,6小时)或粪菌移植(6小时)使死亡率降低50%。
  • 两种干预均完全逆转肠黏膜萎缩:黏膜厚度(μm)假手术组620±35、CLP组411±52、氢化可的松组622±19、粪菌移植组617±44。
  • 氢化可的松和粪菌移植均降低隐窝活化caspase-3阳性肠上皮细胞数(个/10隐窝):假手术组1.6±0.5、CLP组5.8±2.4、氢化可的松组3.6±0.9、粪菌移植组2.3±0.6。
  • CLP降低紧密连接蛋白表达,氢化可的松提高occludin至51±17%、claudin-1至77±9%,粪菌移植提高occludin至56±15%、claudin-1至84±7%(假手术组分别为92±8%和98±4%,CLP组分别为34±12%和35±7%)。
  • 两种干预均降低全身内毒素血症(EU/mL):假手术组0.93±0.36、CLP组2.14±1.74、氢化可的松组1.48±0.53、粪菌移植组1.61±0.58;粪菌移植还降低IL-6和IL-10水平。

适用人群与场景

  • 成年雄性Wistar大鼠盲肠结扎穿孔(CLP)诱导的多微生物脓毒症模型。

处置流程与药物剂量

  • 氢化可的松2.8 mg/kg腹腔注射单次给药,于CLP后6小时给予(组III)。
  • 粪菌移植于CLP后6小时给予(组IV)。
  • 第二实验中存活大鼠每日给予氢化可的松(组III)和粪菌移植(组IV)。

研究设计与关键结果

  • 研究类型:动物实验(大鼠CLP脓毒症模型),40只成年雄性Wistar大鼠随机分为四组:假手术组(I)、CLP组(II)、CLP+氢化可的松组(III)、CLP+粪菌移植组(IV)。
  • 主要终点:氢化可的松和粪菌移植使脓毒症大鼠死亡率降低50%。
  • 肠黏膜厚度(μm,均值±标准差):假手术组620±35、CLP组411±52、氢化可的松组622±19、粪菌移植组617±44。
  • 隐窝活化caspase-3阳性肠上皮细胞数(个/10隐窝,均值±标准差):假手术组1.6±0.5、CLP组5.8±2.4、氢化可的松组3.6±0.9、粪菌移植组2.3±0.6。
  • occludin表达(%,均值±标准差):假手术组92±8、CLP组34±12、氢化可的松组51±17、粪菌移植组56±15;claudin-1表达(%,均值±标准差):假手术组98±4、CLP组35±7、氢化可的松组77±9、粪菌移植组84±7。
  • 全身内毒素水平(EU/mL,均值±标准差):假手术组0.93±0.36、CLP组2.14±1.74、氢化可的松组1.48±0.53、粪菌移植组1.61±0.58。
  • 粪菌移植还降低IL-6和IL-10水平;两种干预均增加潘氏细胞计数、降低上皮内CD3+ T淋巴细胞和固有层炎症浸润至对照水平。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Sepsis is a life-threatening syndrome which can progress to multiple organ dysfunction with high mortality. Intestinal barrier failure exerts a central role in the pathophysiological sequence of events that lead from sepsis to multiple organ dysfunction. The present study investigated the role of hydrocortisone (HC) administration and fecal microbiota transplantation (FMT) in several parameters of the gut barrier integrity, immune activation, and survival, in a model of polymicrobial sepsis in rats.

METHODS: Forty adults male Wistar rats were randomly divided into four groups: sham (group I), cecal ligation and puncture (CLP) (group II), CLP + HC (2.8 mg/kg, intraperitoneally single dose at 6 h) (group III), and CLP + FMT at 6 h (group IV). At 24 h post-CLP, ileal tissues were harvested for histological and immunohistochemical analyses while endotoxin, IL-6, and IL-10 levels in systemic circulation were determined. In a second experiment the same groups were observed for 7 days for mortality, with daily administration of hydrocortisone (group III) and FMT (group IV) in surviving rats.

RESULTS: HC administration and FMT significantly reduced mortality of septic rats by 50%. These interventions totally reversed intestinal mucosal atrophy by increasing villous density and mucosal thickness (μm, mean ± SD: Group I: 620 ± 35, Group II: 411 ± 52, Group III: 622 ± 19, Group IV: 617 ± 44). HC and FMT reduced the apoptotic body count in intestinal crypts whereas these increased the mitotic/apoptotic index. Activated caspase-3 expression in intestinal crypts was significantly reduced by HC or FMT (activated caspase-3 (+) enterocytes/10 crypts, mean ± SD: Group I: 1.6 ± 0.5, Group II: 5.8 ± 2.4, Group III: 3.6 ± 0.9, Group IV: 2.3 ± 0.6). Both treatments increased Paneth cell count and decreased intraepithelial CD3(+) T lymphocytes and inflammatory infiltration of lamina propria to control levels. In the sham group almost the total of intestinal epithelial cells expressed occludin (92 ± 8%) and claudin-1 (98 ± 4%) and CLP reduced this expression to 34 ± 12% for occludin and 35 ± 7% for claudin-1. Administration of HC significantly increased occludin (51 ± 17%) and claudin-1 (77 ± 9%) expression. FMT exerted also a significant restoring effect in tight junction by increasing occludin (56 ± 15%) and claudin-1 (84 ± 7%) expression. The beneficial effects of these treatments on gut barrier function led to significant reduction of systemic endotoxemia (EU/mL, mean ± SD: Group I: 0.93 ± 0.36, Group II: 2.14 ± 1.74, Group III: 1.48 ± 0.53, Group IV: 1.61 ± 0.58), while FMT additionally decreased IL-6 and IL-10 levels.

CONCLUSION: Fecal microbiota transplantation and stress dose hydrocortisone administration in septic rats induce a multifactorial improvement of the gut mechanical and immunological barriers, preventing endotoxemia and leading to improved survival.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Assimakopoulos SF, Papadopoulou I, Bantouna D, et al. Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis. Shock. 2021. PMID: 32496421. doi:10.1097/SHK.0000000000001566

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。